International biobanking for lung cancer and COPD as thefuture resource for clinical protein research

Thomas E. Fehniger, Ákos Végvári, Melinda Rezeli, Balázs Döme, József Tímár, György Marko-Varga

Research output: Article

3 Citations (Scopus)

Abstract

Characterized tissue with pathological grading and blood samples as well as other biofluidsforms the basis for all biobanks as a resource in modern life science. Biobanks are accessed tomeasure biological components that can be used to monitor the status of health and diseasein individual samples and population groups. The biomarker diagnostics area, predictingdrug efficacy, stratification of patient groups, can benefit from the continuous qualitativedevelopments, where Proteomics can make a difference in lung cancer and COPD. This inturn can provide key treasures to novel drugs for personalized medicine in the future.

Original languageEnglish
Pages (from-to)3-7
Number of pages5
JournalEuPA Open Proteomics
Volume1
DOIs
Publication statusPublished - jan. 1 2013

    Fingerprint

ASJC Scopus subject areas

  • Biochemistry

Cite this